BIOMAT Database Logo BIOMAT Database Logo

Circulating interferon in patients with acute hepatitis A. 1986

R Zachoval, and J Abb, and V Zachoval, and F Deinhardt

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays

Related Publications

R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Absence of circulating interferon in acute viral hepatitis.
May 1984, Acta virologica,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Failure to detect circulating interferon during acute viral hepatitis.
May 1984, The Journal of infectious diseases,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Absence of circulating interferon in patients with infectious and serum hepatitis.
May 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Endogenous interferon (IFN) in patients with acute hepatitis B.
January 1990, Acta medica Hungarica,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon.
October 1994, Journal of interferon research,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Pegylated interferon alpha-2b in patients with acute hepatitis C.
January 2006, The National medical journal of India,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy.
December 2004, Journal of gastroenterology,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
[A report on therapy of interferon-A2b in patients with acute hepatitis C].
June 1993, Zhonghua nei ke za zhi,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
January 1993, Gut,
R Zachoval, and J Abb, and V Zachoval, and F Deinhardt
Circulating immune complex of hepatitis virus C in patients with acute and chronic hepatitis C.
June 1996, Journal of hepatology,
Copied contents to your clipboard!